128
Participants
Start Date
August 8, 2002
Primary Completion Date
July 22, 2005
Study Completion Date
December 21, 2009
fludarabine phosphate
Centre Hospitalier Lyon Sud, Pierre-Bénite
Centre Jean Bernard, Le Mans
Tom Baker Cancer Center - Calgary, Calgary
Cross Cancer Institute, Edmonton
Providence Health Care - Vancouver, Vancouver
CancerCare Manitoba, Winnipeg
Moncton Hospital, Moncton
Saint John Regional Hospital, Saint John
Newfoundland Cancer Treatment and Research Foundation, St. John's
Nova Scotia Cancer Centre, Halifax
Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury
Margaret and Charles Juravinski Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
Grand River Regional Cancer Centre, Kitchener
Cancer Care Ontario-London Regional Cancer Centre, London
Credit Valley Hospital, Mississauga
Durham Regional Cancer Centre at Lakeridge Health Oshawa, Oshawa
Ottawa Regional Cancer Centre, Ottawa
Algoma Reginal Cancer Program at Sault Area Hospital, Sault Ste. Marie
Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines
Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay
Toronto Sunnybrook Regional Cancer Centre, Toronto
Princess Margaret Hospital, Toronto
St. Joseph's Health Centre - Toronto, Toronto
Humber River Regional Hospital - Weston, Weston
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
CHUS-Hopital Fleurimont, Fleurimont
Hopital Charles Lemoyne, Greenfield Park
Maisonneuve-Rosemont Hospital, Montreal
Centre Hospitalier de l'Universite de Montreal, Montreal
McGill University, Montreal
Hopital de L'Enfant Jesus, Québec
Hopital du Saint-Sacrement, Quebec, Québec
Allan Blair Cancer Centre, Regina
Lead Sponsor
NCIC Clinical Trials Group
NETWORK